Hridayam Heart And Vascular Institute Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 04-07-2024
- Paid Up Capital ₹ 1.00 M
as on 04-07-2024
- Company Age 7 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.85 Cr
as on 04-07-2024
- Revenue 14.04%
(FY 2023)
- Profit 11.30%
(FY 2023)
- Ebitda 5.55%
(FY 2023)
- Net Worth 34.16%
(FY 2023)
- Total Assets 7.26%
(FY 2023)
About Hridayam Heart And Vascular Institute
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹3.85 Cr.
Rashmi Singh and Kamal Adile serve as directors at the Company.
- CIN/LLPIN
U74999CT2017NPL008089
- Company No.
008089
- Company Classification
Private Not For Profit Company
- Incorporation Date
10 Aug 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chhattisgarh
Industry
Company Details
- Location
Raipur, Chattisgarh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Hridayam Heart And Vascular Institute?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rashmi Singh  | Director | 10-Aug-2017 | Current |
| Kamal Adile | Director | 10-Aug-2017 | Current |
Financial Performance of Hridayam Heart And Vascular Institute.
Hridayam Heart And Vascular Institute, for the financial year ended 2023, experienced significant growth in revenue, with a 14.04% increase. The company also saw a substantial improvement in profitability, with a 11.3% increase in profit. The company's net worth Soared by an impressive increase of 34.16%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hridayam Heart And Vascular Institute?
In 2023, Hridayam Heart And Vascular Institute had a promoter holding of 54.99% and a public holding of 45.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mediserve Health Care Private LimitedActive 4 years 11 monthsRashmi Singh and Kamal Adile are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 11 Dec 2017 | ₹3.85 Cr | Open |
How Many Employees Work at Hridayam Heart And Vascular Institute?
Unlock and access historical data on people associated with Hridayam Heart And Vascular Institute, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hridayam Heart And Vascular Institute, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hridayam Heart And Vascular Institute's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
